Research Abstracts

The Journal of Informed Pharmacotherapy 2002;8:410.

Evaluation of Quality of Life in Patients with Congestive Heart Failure Attending a Community Hospital's Heart Function Clinic

Wanbon L, BSc (Pharm), Kanji Z, BSc (Pharm), PharmD, Collins M, BSc (Pharm), MSc (Pharmacol) 

Pharmacy Department, Lions Gate Hospital, North Vancouver, British Columbia, Canada

Canadian Society of Hospital Pharmacists (British Columbia Branch) Residency Research Presentation Night, Vancouver, British Columbia, Canada. May 2001.


A multidisciplinary heart function clinic (HFC) was opened to better facilitate outpatient follow-up for people with congestive heart failure (CHF). Two goals of the HFC were to improve patients' quality of life (QOL) and to bring patients' medication therapy in line with the 1999 American guidelines for CHF management.  To date, no published studies have evaluated QOL in patients on these medications while attending a multidisciplinary outpatient HFC.


To determine the impact of a multidisciplinary HFC on QOL, medication therapy, and medication compliance in patients with CHF.


A Canadian community hospital consisting of 260 acute and 325 extended care beds.


This was a prospective, observational study. 

Main Outcome Measures

To assess QOL, the Short Form 36 (SF-36) Health Status Survey, the Minnesota Living With Heart Failure (MLwHF) Questionnaire, and a global assessment of health were conducted at baseline and after three months, at which time drug therapy and compliance were also assessed.


At follow-up, the clinic group's MLwHF total score was three times better, their physical score was 3.5 times better, and their emotional score was two times better than the control group's scores, respectively. Clinic patients were more likely than control patients to receive beta-blockers and spironolactone when these drugs were indicated. Clinic patients reported higher compliance than control patients.


QOL and medication therapy showed a greater improvement in the clinic group than the control group.

Copyright © 2002 by the Journal of Informed Pharmacotherapy. All rights reserved.